Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Morin

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Dental Materials : Official Publication of the Academy of Dental Materials|January 26, 2019
Hydrophobicity of graphene as a driving force for inhibiting biofilm formation of pathogenic bacteria and fungiShruti Vidhawan Agarwalla, Kassapa Ellepola, Mariana Caldeira Ferraz da Costa, et al.
Analytical and Bioanalytical Chemistry|December 2, 2011
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodiesShujie J Wang, Steven T Wu, Jochem Gokemeijer, et al.
Microbiology Spectrum|October 9, 2023
Application of quasimetagenomics methods to define microbial diversity and subtype <i>Listeria monocytogenes</i> in dairy and seafood production facilitiesBrandon Kocurek, Padmini Ramachandran, Christopher J Grim, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2010
Phenyltriazolinones as potent factor Xa inhibitorsMimi L Quan, Donald J P Pinto, Karen A Rossi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 ExpressionStephanie Robu, Antonia Richter, Dario Gosmann, et al.
Annals of Family Medicine|May 13, 2020
Case Management in Primary Care for Frequent Users of Health Care Services: A Realist SynthesisCatherine Hudon, Maud-Christine Chouinard, Kris Aubrey-Bassler, et al.
Alternatives to Laboratory Animals : ATLA|March 19, 2009
In vitro models of inhalation toxicity and disease. The report of a FRAME workshopKelly BéruBé, Michaela Aufderheide, Damien Breheny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 11, 2022
Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active DosesZheng Yang, Surendran Rajendran, Vanessa Spires, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseRobert G Gentles, Steven Sheriff, Brett R Beno, et al.
Frontiers in Pharmacology|July 7, 2022
Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc Fusion ProteinZheng Yang, James Loy, Brian Poirson, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Dental Materials : Official Publication of the Academy of Dental Materials|January 26, 2019
Hydrophobicity of graphene as a driving force for inhibiting biofilm formation of pathogenic bacteria and fungiShruti Vidhawan Agarwalla, Kassapa Ellepola, Mariana Caldeira Ferraz da Costa, et al.
Analytical and Bioanalytical Chemistry|December 2, 2011
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodiesShujie J Wang, Steven T Wu, Jochem Gokemeijer, et al.
Microbiology Spectrum|October 9, 2023
Application of quasimetagenomics methods to define microbial diversity and subtype <i>Listeria monocytogenes</i> in dairy and seafood production facilitiesBrandon Kocurek, Padmini Ramachandran, Christopher J Grim, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2010
Phenyltriazolinones as potent factor Xa inhibitorsMimi L Quan, Donald J P Pinto, Karen A Rossi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 ExpressionStephanie Robu, Antonia Richter, Dario Gosmann, et al.
Annals of Family Medicine|May 13, 2020
Case Management in Primary Care for Frequent Users of Health Care Services: A Realist SynthesisCatherine Hudon, Maud-Christine Chouinard, Kris Aubrey-Bassler, et al.
Alternatives to Laboratory Animals : ATLA|March 19, 2009
In vitro models of inhalation toxicity and disease. The report of a FRAME workshopKelly BéruBé, Michaela Aufderheide, Damien Breheny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 11, 2022
Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active DosesZheng Yang, Surendran Rajendran, Vanessa Spires, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseRobert G Gentles, Steven Sheriff, Brett R Beno, et al.
Frontiers in Pharmacology|July 7, 2022
Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc Fusion ProteinZheng Yang, James Loy, Brian Poirson, et al.
Pageof 7